Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

NCT03375788 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03375788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03375788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 17, 2019
Completion date
January 10, 2025
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver, liver fat, non-alcoholic fatty liver disease, obesity, obesity, abdominal